Growth Metrics

Calidi Biotherapeutics (CLDI) Notes Payables (2022 - 2025)

Calidi Biotherapeutics' quarterly Notes Payables came in at $400000.0 in Q3 2025, down 87.88% year-on-year from $3.3 million in Q3 2024, and down 50.0% quarter-over-quarter from $800000.0 in Q2 2025.

Calidi Biotherapeutics has reported Notes Payables for 4 years, with the latest figure at $400000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables fell 87.88% year-over-year to $400000.0; the trailing twelve-month figure through Sep 2025 stood at $400000.0 (down 87.88% YoY), and the FY2024 full-year result was $2.7 million, down 18.18% from the prior year.
  • Notes Payables for Q3 2025 stood at $400000.0, down from $800000.0 in the prior quarter.
  • The five-year high for Notes Payables was $3.3 million in Q3 2023, with the low at $400000.0 in Q3 2025.
  • Average Notes Payables over 4 years is $1.9 million, with a median of $1.5 million recorded in 2023.
  • Year-over-year, Notes Payables jumped 617.39% in 2023 and plunged 87.88% in 2025.
  • Tracing CLDI's Notes Payables over 4 years: stood at $1.5 million in 2022, then soared by 120.0% to $3.3 million in 2023, then fell by 18.18% to $2.7 million in 2024, then plunged by 85.19% to $400000.0 in 2025.
  • The last three Notes Payables figures came in at $400000.0 (Q3 2025), $800000.0 (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn
8 Evaxion A 65.44 Bn 65.42 Bn -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn
10 Calidi Biotherapeutics - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 400,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 1.10 Mn
Dec 31, 2024 2.70 Mn
Sep 30, 2024 3.30 Mn
Jun 30, 2024 3.30 Mn
Mar 31, 2024 1.02 Mn
Dec 31, 2023 3.30 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2023 1.49 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.50 Mn
Sep 30, 2022 460,000.00